Prospective reference COL40967 Cohort, 7 150 and death educational category using colorectal cancer g/week Lithuania Age: 40-59 years, 30 years registry smoking, study the Hamling’s M method Age, aspirin use, BMI, calcium, NHS-HPFS, calendar period, Prospective endoscopy, Cho, 2012 1801/ Questionnaire Incidence, colon Cohort, 2.03 (1.11-3.71) energy intake, COL40902 135 151 and mortality FFQ cancer, family 30 vs 0 g/day Midpoints M/W, Ptrend:0.69 folate, HRT use, U.S 26 register history of crc Health menopausal professionals status, pack yrs of smoking, red meat Age, BMI, 1 255/ Incidence, calcium, energy 41 836 vs g/day 1.00 (0.71-1.40) ≥31 ≤0 colorectal cancer intake, 16 years exogenous Incidence, IWHS, female 633/ proximal vs g/day 1.12 (0.71-1.77) ≥31 ≤0 Razzak, 2011 Prospective Cancer registry hormones, fat Mid-points of cancer COL40889 Cohort, and pathology intake, folate, exposure FFQ USA Age: 55-69 years, register methionine, categories. W physical activity, red Incidence, distal 594/ vs g/day 0.89 (0.54-1.50) ≥31 ≤0 meat, smoking colon cancer status, sucrose, vitamin e, whr
COL40967 Lithuania Prospective Cohort, Age: 40-59 years, M 7 150 30 years and death registry colorectal cancer g/week educational smoking, study reference category using the Hamling’s method Cho, 2012 COL40902 U.S NHS-HPFS, Prospective Cohort, M/W, Health professionals 1801/ 135 151 26 Questionnaire and mortality register FFQ Incidence, colon cancer, family history of crc 30 vs 0 g/day 2.03 (1.11-3.71) Ptrend:0.69 Age, aspirin use, BMI, calcium, calendar period, endoscopy, energy intake, folate, HRT use, menopausal status, pack yrs of smoking, red meat Midpoints Razzak, 2011 COL40889 USA IWHS, Prospective Cohort, Age: 55-69 years, W 1 255/ 41 836 16 years Cancer registry and pathology register FFQ Incidence, colorectal cancer ≥31 vs ≤0 g/day 1.00 (0.71-1.40) Age, BMI, calcium, energy intake, exogenous female hormones, fat intake, folate, methionine, physical activity, red meat, smoking status, sucrose, vitamin e, whr Mid-points of exposure categories. 633/ Incidence, proximal cancer ≥31 vs ≤0 g/day 1.12 (0.71-1.77) 594/ Incidence, distal colon cancer ≥31 vs ≤0 g/day 0.89 (0.54-1.50)